BIOCRYST PHARMACEUTICALS INC Operating Lease, Payments in USD from 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to Q1 2025.
  • Biocryst Pharmaceuticals Inc Operating Lease, Payments for the quarter ending March 31, 2025 was $385K, a 26.7% decline year-over-year.
  • Biocryst Pharmaceuticals Inc annual Operating Lease, Payments for 2024 was $2.16M, a 12.3% increase from 2023.
  • Biocryst Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $1.92M, a 23.5% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $1.56M, a 4.36% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

BIOCRYST PHARMACEUTICALS INC Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $385K -$140K -26.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $2.02M $525K +$102K +24.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $1.92M -$83K +$158K +65.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $1.76M $834K +$219K +35.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.54M $746K +$139K +22.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $1.4M $423K -$151K -26.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.56M -$241K -$606K -166% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 $2.16M $615K +$309K +101% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $1.85M $607K +$228K +60.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.62M $574K +$134K +30.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $1.49M $365K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $306K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $379K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $440K +$32K +7.84% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $408K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07

BIOCRYST PHARMACEUTICALS INC Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.16M +$236K +12.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $1.92M +$365K +23.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $1.56M +$65K +4.36% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $1.49M -$206K -12.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $1.7M +$239K +16.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $1.46M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.